Hit enter to search or ESC to close
YOZMA GROUP KOREAYOZMA GROUP KOREA
Menu
  • About
    • Overview
    • Our Team
  • Business
    • Investment
    • Accelerator
    • Consulting
    • Tech Transfer
  • Campus
    • Overview
    • Partners
    • Portfolio
  • Portfolio
  • Newsroom
    • News
    • Press Release
    • Video
  • Contact
    • Recruit
  • English
    • Korean
  • About
    • Overview
    • Our Team
  • Business
    • Investment
    • Accelerator
    • Consulting
    • Tech Transfer
  • Campus
    • Overview
    • Partners
    • Portfolio
  • Portfolio
  • Newsroom
    • News
    • Press Release
    • Video
  • Contact
    • Recruit
  • English
    • Korean
Selvas Healthcare-funded UltraSight receives FDA clearance for AI cardiac ultrasound technology
News

Selvas Healthcare-funded UltraSight receives FDA clearance for AI cardiac ultrasound technology

By 관리정경단2023-07-28July 31st, 2023No Comments

Home » Selvas Healthcare-funded UltraSight receives FDA clearance for AI cardiac ultrasound technology

Selvas Healthcare-funded UltraSight receives FDA clearance for AI cardiac ultrasound technology

https://www.mk.co.kr/news/business/10795693

Tags:

FDAselvashealthcareultrasight
  • Previous PostMaeil Business Newspaper Interview - Moshe Ben-bassat, Chairman of Plataine

  • Next PostFDA Grants Clearance for UltraSight's AI cardiac ultrasound technology

Seoul Office
9F, 457, Bongeunsa-ro, Gangnam-gu, Seoul, Republic of Korea
t. +82 2 6949 5350
e. [email protected]

Israel Office
2 Ben Gurion way, BSR 1 building fl 14, Ramat Gan, Israel
e. [email protected]

Family Site →
  • Privacy Policy

© 2025 Yozma Group Korea.